La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Cannabis Suisse a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Cannabis Suisse..

Cannabis Suisse (OTC:CSUI) Azioni, Catena delle Opzioni

Cannabis Suisse Corp is engaged in the rental of commercial office and industrial space.

CANNABIS SUISSE CORP by Cannabis Suisse Corp.

Cannabis Suisse Corp

Tether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDT</a>) on Monday announced it has acquired a Digital Asset Service Provider (DASP) license by El Salvador, allowing it to subsequently relocate its operations to <a href="https://www.benzinga.com/news/25/01/42893089/el-salvadors-nayib-bukele-says-maybe-well-all-get-the-chance-to-buy-bitcoin-at-a-discount-after-doj-clears-sale-of-over-69k-btc">the Central American nation</a>.
What Happened: In a press release, the company stated El Salvador&#8217;s crypto-friendly policies, favorable regulations and adoption of digital assets by its citizens prompted the decision to relocate.
&#8220;This strategic positioning is helping to shape the future of financial systems, making the country a key player in the global fintech landscape,&#8221; Tether stated.
The company further stated that its move to El Salvador positions it to scale its efforts in supporting financial inclusion leveraging Bitcoin and stablecoin adoption in underserved regions.
It added that the move enhances Tether's flexibility to explore &#8220;groundbreaking&#8221; solutions in a supportive regulatory and business environment.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42946219/microstrategy-acquires-2530-bitcoin-for-243m-reaching-450000-btc-in-total-holdings">MicroStrategy Acquires 2,530 Bitcoin For $243M, Reaching 450,000 BTC In Total Holdings</a>
Why It Matters: Tether is under scrutiny by U.S. federal authorities for potential sanctions and alleged <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41555467/federal-probe-into-tether-examines-potential-sanctions-and-money-laundering-breaches-wsj">anti-money laundering violations</a>.
In November 2024, unsealed court filings revealed that Mexican and Colombian drug cartels have used Tether and Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) for <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42166673/drug-cartels-use-tether-and-bitcoin-to-launder-millions-court-documents-reveal">laundering millions of dollars. </a>
The documents detail how groups like the Sinaloa cartel exploit stablecoins to move wealth across borders through peer-to-peer networks, over-the-counter trades, and currency exchanges.
A source disclosed to investigators that cartels often buy USDT in Mexico below market rates—given its connection to illicit funds—and later sell it in Colombia. 
These activities are complemented by blockchain transactions that obscure the origins of funds, including conversions to Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>).
Investigations have also uncovered substantial cryptocurrency activity linked to these cartels. 
For example, a Binance account under investigation processed $15 million in suspicious transactions between 2020 and 2023. 
Tether itself has reported working with global law enforcement agencies on over 195 cases involving illicit activities, blocking more than $2 billion in USDT tied to criminal operations.
The company's CEO Paolo Ardoino did not respond to a request for comment
Read Next:
<ul>
<li> <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42944474/donald-trump-jr-joins-kalshi-prediction-market-as-strategic-advisor">Donald Trump Jr. Joins Kalshi Prediction Market As Strategic Advisor</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

$BTC

$ETH

$USDT

Tether To Relocate Headquarters To El Salvador

Morgan Stanley analyst Benjamin Swinburne maintains Warner Music Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WMG#NASDAQ">WMG</a>) with a Overweight and lowers the price target from $38 to $37.

Price Target

Analyst Ratings

Morgan Stanley Maintains Overweight on Warner Music Gr, Lowers Price Target to $37

Morgan Stanley analyst Matthew Cost maintains Unity Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>) with a Overweight and raises the price target from $24 to $26.

Morgan Stanley Maintains Overweight on Unity Software, Raises Price Target to $26

Biotech

General

Pfizer CEO Albert Bourla Says "Looking At Everything" In The Obesity Market Beyond Injectable GLP-1 Drugs; Says "All In" On Obesity Drug Development

Morgan Stanley analyst Vincent Andrews maintains Tronox Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TROX#NYSE">TROX</a>) with a Equal-Weight and lowers the price target from $16 to $12.

TROX

Morgan Stanley Maintains Equal-Weight on Tronox Holdings, Lowers Price Target to $12

Morgan Stanley analyst Matthew Cost maintains Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) with a Overweight and raises the price target from $130 to $145.

Morgan Stanley Maintains Overweight on Trade Desk, Raises Price Target to $145

Morgan Stanley analyst Tejas Savant maintains Thermo Fisher Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) with a Overweight and lowers the price target from $670 to $647.

Morgan Stanley Maintains Overweight on Thermo Fisher Scientific, Lowers Price Target to $647

<a href="https://www.bloomberg.com/news/articles/2025-01-13/lilly-asks-biden-administration-to-pause-drug-price-negotiations?srnd=homepage-europe">https://www.bloomberg.com/news/articles/2025-01-13/lilly-asks-biden-administration-to-pause-drug-price-negotiations?srnd=homepage-europe</a>
&nbsp;
Drugmaker Eli Lilly &amp; Co. has asked the US government to pause its forward march with drug-price negotiations, potentially thwarting the Biden administration's plans to release a new list of drug targets before leaving office next week.&nbsp;

Politics

'Lilly Asks Biden Administration to Pause Drug-Price Negotiations' - Bloomberg News

Insmed's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NYSE">INSM</a>) short percent of float has risen 18.59% since its last report. The company recently reported that it has 15.44 million shares sold short, which is 8.74% of all regular shares that are available for trading. Based on its trading volume, it would take traders 8.63 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Insmed Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736792122_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Insmed has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Insmed's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Insmed's peer group average for short interest as a percentage of float is 5.01%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

INSM

How Is The Market Feeling About Insmed?

GitLab's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NYSE">GTLB</a>) short percent of float has risen 45.91% since its last report. The company recently reported that it has 7.46 million shares sold short, which is 6.07% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.68 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>GitLab Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736792117_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for GitLab has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing GitLab's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, GitLab's peer group average for short interest as a percentage of float is 5.22%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

GTLB

How Is The Market Feeling About GitLab?

Morgan Stanley analyst Elizabeth Porter maintains Sprout Social (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPT#NASDAQ">SPT</a>) with a Equal-Weight and raises the price target from $36 to $37.

Morgan Stanley Maintains Equal-Weight on Sprout Social, Raises Price Target to $37

Summit Materials's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUM#NYSE">SUM</a>) short percent of float has risen 14.44% since its last report. The company recently reported that it has 6.59 million shares sold short, which is 5.47% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.94 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Summit Materials Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736792112_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Summit Materials has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Summit Materials's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Summit Materials's peer group average for short interest as a percentage of float is 2.96%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(SUM) - Analyzing Summit Materials's Short Interest

Morgan Stanley analyst Stefan Diaz maintains Sealed Air (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SEE#NYSE">SEE</a>) with a Equal-Weight and lowers the price target from $39 to $38.

Morgan Stanley Maintains Equal-Weight on Sealed Air, Lowers Price Target to $38

Morgan Stanley analyst Matthew Cost maintains Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) with a Overweight and raises the price target from $65 to $75.

RBLX

Morgan Stanley Maintains Overweight on Roblox, Raises Price Target to $75

Morgan Stanley analyst Brian Nowak maintains Pinterest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>) with a Equal-Weight and raises the price target from $35 to $36.

PINS

Morgan Stanley Maintains Equal-Weight on Pinterest, Raises Price Target to $36

Morgan Stanley analyst Angel Castillo maintains Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) with a Underweight and lowers the price target from $41 to $31.

Morgan Stanley Maintains Underweight on Olin, Lowers Price Target to $31

Morgan Stanley analyst Nigel Dally maintains Mosaic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOS#NYSE">MOS</a>) with a Equal-Weight and lowers the price target from $40 to $30.

Morgan Stanley Maintains Equal-Weight on Mosaic, Lowers Price Target to $30

Morgan Stanley analyst Brian Nowak maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Overweight and raises the price target from $600 to $660.

Morgan Stanley Maintains Overweight on Meta Platforms, Raises Price Target to $660

Morgan Stanley analyst Nathan Feather maintains Match Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) with a Equal-Weight and raises the price target from $31 to $32.

MTCH

Morgan Stanley Maintains Equal-Weight on Match Group, Raises Price Target to $32

Citigroup analyst Andrew Kaplowitz maintains Xylem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYL#NYSE">XYL</a>) with a Buy and lowers the price target from $148 to $147.

Comments

Cannabis Suisse

Cannabis Suisse (CSUI) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO